|View printer-friendly version|
|CytomX to Present Probody Overview at the Credit Suisse Antibody Day|
SOUTH SAN FRANCISCO, Calif., May 5, 2015 – CytomX, a biotechnology company developing Probody™ therapeutics for the treatment of cancer, today announced that Sean McCarthy, D. Phil., chief executive officer, will present at the Credit Suisse Antibody Day in New York at 1:15 p.m. EDT on Wednesday, May 6. Dr. McCarthy will present an overview of CytomX’s Probody pipeline, including the company’s Precision cancer immunotherapy and Probody drug conjugate programs.